Background
Valvular heart disease is classically predominated by rheumatic heart disease (RHD) in the young in lowresource settings and by calcific aortic valvluar disease in the elderly in high-resource settings [1] [2] [3] . In the last decade, studies from across the African continent have begun to provide a better understanding of RHD across the continent, with important advances in epidemiology, diagnosis, and outcomes [4] [5] [6] [7] [8] [9] [10] [11] .
However, the last two decades have witnessed a substantial increase in life expectancy in sub-Saharan Africa [12] , and more of the population is living past the 7th decade of life. It stands to reason that the etiology of valvular heart disease may also be shifting, as has been documented in middle-income countries [13] [14] [15] .
The Uganda Heart Institute (UHI) provides cardiology tertiary referral for the country of Uganda, with diagnostic echocardiography and both pediatric and adult cardiologists with expertise in echocardiographic performance and interpretation. The objective of this study was to classify the burden of primary left-sided valvular heart disease across the lifespan in Uganda, through retrospective study of a large cohort of patients evaluated at UHI over a two-year period.
Methods

Study design
This was a retrospective review of echocardiographic reports for studies performed between January 2012 and December 2013 (24 months) at UHI.
Study site
UHI is a specialized tertiary centre for cardiovascular care in Uganda, located within Mulago Hospital Complex, the country's national referral hospital and teaching hospital for Makerere University Medical School. The adult (≥ 13 years) echocardiography laboratory serves approximately 10,000 patients per year with three fully functional echocardiography machines (2 x GE medical Systems Vivid 7 Dimension -GE Vingmed Ultrasound AS N-3190 Horten, Norway and 1 x Phillips IE33 -Phillips Ultrasound Bothell WA, 98041 USA).
Study population
The study population consisted of adults who had an echocardiogram performed at UHI during the study period. Only the first echocardiographic report from each patient during the study period was utilized for data collection. Retrospective echo report review was performed for all patients ≥13 years. Patients with an incomplete echocardiography report, those found to have no structural heart disease, those with unclear etiology of valvular disease, those with secondary/functional leftsided valvular regurgitation and those with non-valvular cardiac structural abnormalities were excluded from further data analysis (Fig. 1) .
Echocardiography procedures
Echocardiograms were performed by adult cardiologists or cardiology fellows in accordance with the American Society of Echocardiography guidelines [16, 17] . Although these echocardiographic studies were performed in 2012 and 2013, we reviewed the valve parameters provided in the echocardiography reports and graded the severities of valve dysfunction (regurgitation and/or stenosis) according to the 2014 and 2017 guidelines for the management of patients with valvular heart disease [18] [19] [20] [21] (Table 1) . The etiology of the valve dysfunction remained the same as that which was reported in the original reports. Care was always taken during the echocardiography studies to exclude secondary mitral regurgitation due to dilated cardiomyopathy and ischemic heart disease before making a diagnosis of "primary mitral regurgitation" [18, 21] .
Diagnostic classification
Patients with primary left-sided valvluar heart disease were categorized into one of 5 major categories:
1. Rheumatic Heart Disease (RHD), which was diagnosed according to the 2012 World Heart Federation criteria [22] was based on the typical echocardiographic features that have been described [29, 30] .
In each of these diagnostic categories, patients were further classified according to the 2014 ACC/AHA staging of primary VHD [18] . 
Other echocardiographic assessments
Examination of native or prosthetic valves for echocardiographic features of past or current infective endocarditis was performed according to standard guidelines [31, 32] . Prosthetic valves were evaluated according to the 2009 American Society of Echocardiography's Guidelines for the echocardiographic evaluation of prosthetic valves [31] .
Data management
Data was initially captured in Epi info 3.0 and later exported to Stata 12.0. Continuous variables are presented as means ± standard deviation. Categorical variables are presented as proportions.
Results
Of 20,986 echocardiographic studies performed during the study period, 3582 were included in the data analysis ( Fig. 1 ). Over 60% of the 3582 patients were females ( Table 2 ). The diagnostic category of "sclerotic valve changes with normal valve function" accounted for 98% of the primary valve diseases in Stage A while rheumatic heart disease accounted for over half of the primary valve diseases in Stages B to D (Fig. 2 ).
"Stage a" primary left-sided valve diseases
"Sclerotic valve changes with normal valve function" overshadowed all the other valve diseases in this stage (Fig. 2) . All of the patients with sclerotic valve changes with normal valve function were aged ≥40 years and 56% were males. There were much smaller numbers of patients "at risk" of progressive RHD, BAV, MVP and EMF-related valve dysfunction.
"Stages b, c and d" primary left-sided valve diseases
RHD was the leading cause of valve disease in these categories and was closely followed by DVD. The other diagnostic categories occurred in much smaller numbers. Isolated mitral regurgitation was the most common rheumatic valve lesion. RHD disproportionately affected the young under-40 years age group, with the 'number of cases per age group' falling below that of DVD in the 5th decade of life (Fig. 4) . b) Degenerative Valve Disease Calcific degenerative mild to severe valve disease was the second common diagnostic category, following closely after RHD (Fig. 2) . The 'number of cases per age group' increased with age, peaking in the 70-79 year age group (Fig. 4) . Mitral regurgitation was the most predominant degenerative valve lesion (Fig. 5 ). c) Bicuspid Aortic Valve Twenty-nine patients were reported to have bicuspid aortic valves. Sixteen (55%) were males, and there was a fair distribution among all the age groups (Fig. 6) . Majority of the affected patients had severe aortic valve dysfunction while 1 patient had undergone aortic valve replacement (Fig. 7) . Two patients had co-existing coarctation of the aorta, 2 patients had ascending aortic aneurysmsa manifestation of bicuspid aortopathy while 1 patient had echocardiographic evidence of aortic valve endocarditis. There were no reports of other congenital structural valve abnormalities like cleft mitral valve, parachute mitral valve or sub-mitral aneurysms over the 24 months. d) Primary Mitral Valve Prolapse Twenty three patients had definite primary classic or non-classic mitral valve prolapse. Majority of these were teenagers (Fig. 8) . All the cases were reported to be myxomatous in origin. Three patients were reported to have co-existent aortic leaflet prolapse but with preserved aortic valve function in all the cases. Of the 23 individuals with MVP, 3 had severe, 8 had moderate, 7 had mild while 5 had no mitral valve regurgitation. e) Endomyocardial Fibrosis Twenty-two patients had moderate to severe mitral valve regurgitation due to involvement of the mitral valve in left ventricular or biventricular endomyocardial fibrosis. EMF was exclusively diagnosed in the 13-39 years age groups, and 72% of the patients were females.
Other findings a) Infective Endocarditis
Infective endocarditis is not presented as a separate diagnostic category because there were no reports of "primary" endocarditis. All the cases of left-sided infective endocarditis that were reported were super-imposed on another form of primary valve disease. Echocardiographic evidence of past or active mitral and/or aortic valve infective endocarditis was reported in 39 patients. RHD was the predominant predisposing factor and the mitral valve was most commonly affected (Fig. 9) . One patient had an aortic root abscess while the rest of the patients had mitral and/or aortic valve vegetations. A description of further work up to confirm active infection and the causative organisms is beyond the scope of this paper. b) Prosthetic Valves Fifty patients had undergone mitral and/or aortic valve replacement procedures. RHD was overwhelmingly the leading indication for valve (Table 3 ). The majority of valve replacements were performed when patients were under 30 years of age (Fig. 10) . All the prosthetic valves were functioning normally. One patient had evidence of vegetations on a mechanical mitral prosthesis but the valve function was normal.
Discussion
In this study, we describe the burden of a variety of forms of primary left-sided valve disease from a large series of echocardiographic studies in a tertiary cardiac care centre in Uganda.
We demonstrated a large number of patients in this series with "sclerotic valve changes with normal valve function". This early stage of leaflet changes is recognized as "Stage A" or the "initiation stage" of progressive DVD, and indicates a population that is at risk of developing progressive valve stenosis or regurgitation [18] [19] [20] [21] 24] . Progressive valve disease develops in approximately 10-15% of patients with valve sclerotic changes, and this category of patients has been shown to have an increased risk of cardiovascular events over 5 years [24] . Although previous randomized clinical trials of lipid-lowering therapy in adults with mild-tomoderate aortic stenosis showed no significant effect on disease progression or aortic-valve events [33] , this early "initiation" stage remains a potential opportunity for medical intervention to prevent or delay disease progression.
Rheumatic heart disease was the leading cause of primary left-sided valve disease with valve dysfunction. There is already a bulk of descriptive data on patterns, presentations, and complications of RHD in Africa andin particular, from the current study site by the same working group [4] [5] [6] [7] [8] [9] [10] [11] . In high income countries, VHD is typically degenerative and is regarded as an emerging public health problem [2] . Degenerative valve disease closely tallied behind RHD among the diagnostic categories with valve dysfunction in this echocardiographic series. In what appears to be quite a similar black South-African study population, Sliwa et al. [14] reported a prevalence of 21% of DVD among structural valve abnormalities. Differences in reporting methods and slight variations in the study populations do not permit direct comparison, but it is evident that the problem of DVD is not as minor in developing countries as it is assumed to be. With improvement in socioeconomic living conditions and increasing life expectancy in Africa [12] ; more cases of DVD should be expected as we experience our share of the epidemiological transition of VHD.
Bicuspid aortic valve (BAV) is the commonest congenital cardiac abnormality in the general population with an estimated prevalence of 1-2% [34] . Although the findings in this study are far from being representative of the general population of Uganda, we bring into the limelight the existence of a pathology in a setting where there is barely any prior literature recording. In Uganda, only a singleton remote documentation by Somers and Rankin in 1962 [35] of a case of aortic coarctation co-existing with BAV can be found. The medical fraternity needs to master its natural progression, as evidenced by the proportions of patients with mild to severe degrees of valve dysfunction, and other clinical components of this pathology such as indications and timing of surgical intervention, infective endocarditis, and bicuspid aortopathy, as demonstrated in this echocardiographic series. Primary MVP contributed 1.4% to the pool of primary valve diseases in stages B-D. Despite the study population and reporting differences, our findings rhyme closely with those of Sliwa et al. [14] who reported a prevalence of MVP of 1% among 481 black patients with structural heart disease. Majority of the patients with MVP were young and had mild to moderate mitral regurgitation, similar to what several population-based studies have demonstrated. Severe mitral regurgitation was less common [27, 36] .
Recognized as the country where EMF was first described [37, 38] , Uganda has remained an endemic region for the disease. EMF is one of the neglected cardiovascular diseases whose etiology and pathogenesis remain elusive, the natural history is incompletely understood and therefore, no effective therapy is currently available [29, 39] . It remains an important cause of heart failure in endemic areas, comparable to rheumatic heart disease. The mechanisms by which heart failure develops are multifactorial with valvular involvement and dysfunction inclusive. Concerted efforts from local scientists, communities, governments and international collaborations are needed for renewed interest in this neglected tropical disease.
Infective endocarditis is an important component of VHD, with the predisposing factors in developing countries strikingly different from those in developed countries. Despite its clinical impact and poor outcomes in our setting, data on this subject are missing or sparse in many low-and middle-income regions [40] . Previous studies in sub-Saharan Africa including the current study site have reported on the burden of infective endocarditis (IE) among patients with RHD [11, 14, 41, 42] . A few prospective and retrospective descriptive studies on etiology and risk factors for IE have been performed in some parts of Africa, and they report RHD to be the leading risk factor for IE [43, 44] . In keeping with these previous reports, RHD was the identifiable predisposition in 94% of patients with echocardiographic features of IE in our study. The only detailed description of IE in Uganda dates back to 1972 [45] , at which time a preponderance of RHD as the predisposing factor was found in 65% of patients in the clinically diagnosed series. For purposes of achieving up-to-date local clarity, our team is currently conducting a prospective study of the risk factors and etiology of infective endocarditis in Mulago National Referral Hospital. RHD was the leading indication for valve surgery in this series as opposed to developed countries where degenerative valve disease takes the lead. Valve surgery is becoming more accessible in Uganda and therefore the number of patients with prosthetic valves is consistently on the rise. By definition, valve disease is still present after interventional therapy and prosthetic valves are a recognized independent entity of valve heart disease. The clinical issues surrounding the timing of valve surgery, prosthetic valve selection, prosthetic valves and pregnancy, anticoagulation and infective endocarditis pose a new frontier in a developing country that all practicing clinicians must get conversant with.
Strengths and limitations
This descriptive study provides vital information that should act as a basis for more focused and analytical studies in the field of valve heart disease in Uganda and developing countries at large. The main limitation of this study is its retrospective nature and thus the inherent shortcoming of incomplete data among others. Also, these findings do not reflect the burden of valve heart disease in the general population of Uganda.
Conclusions
Over the past years, a picture has been painted which gives a reflection that "valve heart disease in Africa is synonymous with rheumatic heart disease in Africa". Our bringing to the limelight by way of publication of the contemporary footprints of other forms of VHD in significant proportions suggests that this assumption is not true. National and continental programs already exist for rheumatic heart disease. A similar coordinated multidisciplinary approach to research, education and clinical management is now needed to ensure improved outcomes for patients with other forms of VHD. 
